The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

GLOBAL MARKETS-Stocks at record high but yields fall, dollar under pressure

Fri, 27th Nov 2020 20:02

* Highly anticipated vaccine facing more scrutiny

* Treasury yields fall, point to lingering COVID-19 worries

* Bitcoin extends Thursday's big losses

* USD index closes at 2-1/2 year low

* U.S. markets on shortened hours after Thanksgiving holiday

* Graphic: 2020 asset performance http://tmsnrt.rs/2yaDPgn

* Graphic: World FX rates in 2020 http://tmsnrt.rs/2egbfVh
(Updates to U.S. market close)

By Rodrigo Campos

NEW YORK, Nov 27 (Reuters) - Stocks rose across the globe on Friday to close
at a fresh high and remained on track for their strongest monthly performance on
record but the Nasdaq outperformed on Wall Street and Treasury yields fell,
indicating lingering concerns over rising coronavirus cases globally.

A global stock index touched a record high for the third session this week
while the dollar index, a measure of the greenback versus six peers, touched a
three-month low and closed at its lowest since April 2018.

On Wall Street, the main indexes rose and the Nasdaq Composite hit a record
high. The Nasdaq outperformance mirrors recent sessions when, despite rising
stocks, the focus was on the economic impact of the pandemic. The U.S. expects a
further surge in coronavirus infections following the Thanksgiving holiday.

The Dow Jones Industrial Average rose 37.9 points, or 0.13%, to
29,910.37, the S&P 500 gained 8.7 points, or 0.24%, to 3,638.35 and the
Nasdaq Composite added 111.44 points, or 0.92%, to 12,205.85.

European stocks rose after the European Central Bank reinforced expectations
of further stimulus next month and Sweden's Riksbank made a surprise increase to
its quantitative-easing program.

The pan-European STOXX 600 index rose 0.41% and MSCI's gauge of
stocks across the globe gained 0.39% to 623.75 after touching a
high of 624.29.

Emerging market stocks rose 0.12%, while Japan's Nikkei rose 0.40%.

Questions also lingered over trial data on AstraZeneca's COVID-19
"vaccine for the world," as several scientists sounded caution over the trial
results.

Australian shares ended down 0.5% with Treasury Wine Estates
down 11.25% as China imposed new tariffs on Australian wine, the latest
move in the countries' long-running trade row.

The European Union and Britain said substantial differences remained over a
Brexit trade deal, as the EU chief negotiator prepared to travel to London in a
last-ditch attempt to avoid a tumultuous finale to the five-year crisis.

Sterling, which has climbed over 3% against the dollar this month, was last
trading at $1.3299, down 0.42% on the day.

"Clearly, there are substantial and important differences still to be
bridged, but we're getting on with it," British Prime Minister Boris Johnson
told reporters.

The dollar index fell 0.269%, with the euro up 0.39% to
$1.196. The Japanese yen strengthened 0.24% versus the greenback at 104.03 per
dollar.

"Over the longer term, this is probably the right trend for the dollar. We
think the dollar has further room to the downside," said Bipan Rai, North
America head of foreign exchange strategy at CIBC Capital Markets.

The yield on benchmark Treasury notes fell as some investors
sought the safety of holding government debt over persistent concerns about the
surge in coronavirus cases and lockdowns in several U.S. states and around the
world.

The 10-year notes last rose 11/32 in price to yield 0.8422%, from 0.878%
late on Wednesday.

Oil prices, up for a fourth straight week, were mixed.

U.S. crude recently fell 0.42% to $45.52 per barrel and Brent
was at $48.27, up 0.98% on the day. Both rose over 7% this week.

Bitcoin fell 2.25% to $16,774.49 after tumbling 8.4% in the
previous session. The cryptocurrency brushed against its record high of $19,666
earlier this week and has rallied around 130% this year.

Spot gold dropped 1.3% to $1,787.40 an ounce. Silver fell
3.20% to $22.70.

(Reporting by Rodrigo Campos; additional reporting by Sinéad Carew in New York,
Marc Jones in London and Shivani Kumaresan in Bengaluru
Editing by Nick Zieminski
)

More News
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.